FDA OK’s Cholesterol Drug Lipitor for Diabetics

March 21st, 2005 Researchers from North Shore-Long Island Jewish Health System in Manhasset, N.Y. have identified a gene which expresses as a protein called macrophage migration inhibitory factor, or MIF.

April 13th, 2005 OPTOMETRY researchers at Aston University’s new £10 million Academy of Life Sciences are currently undertaking ground-breaking research into the vision problems caused by diabetics – one of the leading causes of blindness and vision loss in the UK. So far, the study has been very successful with a large number of diabetic volunteers stepping forward to take part in the study, but the researchers still require some more Type 1 diabetics (insulin dependent patients usually diagnosed under the age of 30) in order to obtain reliable results.

April 3rd, 2005 Since most patients with diabetes die from some vascular complication, Medical College of Georgia researchers set out to determine the effects of simvastatin on endothelial cell dysfunction, an early pivotal event in atherogenesis and a major cause of the microvascular complications in diabetics. The researchers found that in addition to lowering cholesterol levels, simvastatin also appeared to prevent or reverse vascular injury by vasoprotective means.

September 29th, 2005 The Food and Drug Administration warned doctors on Thursday about reports of suicidal thinking in some children and adolescents who are taking Strattera, a drug used to treat attention deficit hyperactivity disorder (ADHD). Manufacturer Eli Lilly & Co.

April 11th, 2005 It is not how obese you are but the location of obesity that matters according to researchers at the University of Pittsburgh Medical Center. Where adults carry their fat, rather than how much of it they have, might be a better indicator of their risk for metabolic syndrome, a disorder that causes high blood pressure and insulin resistance in 22 percent of U.S.

June 19th, 2007 Diabulimia is a new term used to describe an eating disorder that’s beginning to victimize type I diabetics. As with any other eating disorder teens are the most likely to develop it.

February 5th, 2007 India is the ideal place to conduct human trial for the effectiveness of DCA ( dichloroacetate ) as anti-cancer drug. The government regulations for human trial aren't as stringest as USA, there are funds available for such studies and frankly you don't need much.

May 18th, 2005 Valsartan, commercially known as Diovan, a drug that controls blood pressure and reduces heart risk, also appears to protect against diabetes, especially in high-risk people, according to new research presented at the American Society of Hypertension's Twentieth Annual Scientific Meeting and Exposition (ASH 2005) by a University of Michigan physician who helped lead the study. The randomized trial involved 15,313 patients at 942 sites in 31 countries, of whom 9,995 did not have diabetes at the start of the study.

July 8th, 2005 Merck tried to patent a drug that would reduce heart attack risks for Vioxx (COX-2 selective inhibitors) users, three years before the company withdrew the painkiller drug from the market because of safety concerns. According to government records, the company applied for the patent in 2001.

July 23rd, 2005 A doctor told jurors yesterday in the nation's first Vioxx lawsuit that the drug contributed to the death of a Texas man, aged 59, who had an arrhythmia linked to a heart attack in 2001. ''His taking of Vioxx caused and/or contributed to his heart attack," Dr.

July 17th, 2005 The European study of patients with Type I diabetes found that short-term treatment lowered insulin dependence by 12 percent and increased insulin-making capabilities for at least 18 months. "The results are very promising.

August 2nd, 2005 Neuralyzers, a fictional device to wipe memories or re-program them, became popular with Men in Black movie series. Scientists report that beta-blockers (like Atenolol), a popular blood pressure reducing drug, can be effectively used to wipe out bad memories, in other words neuralyzers for common man.

August 13th, 2005 A cheap drug, enfurvitide, has shown promise in stamping out hidden pockets of HIV in three people who have long been infected with the virus. The result is described by the US scientists as merely a “proof of concept”, but has inevitably sparked talk of a cure for AIDS.

June 10th, 2005 Three Transplant Patiet have died due to rare infection (LCMV virus) from rats, raises concern for all transplant patients. On a different front educated women are less likely to suffer from insomnia. And it appears that milk is destined to make a comeback. It had really a bad press all along.

February 3rd, 2007 Investigators at the University of Alberta have recently reported that the drug DCA is able to cause tumor regression in a number of human cancers growing in animals. The drug, dichloroacetate (DCA), is being used for years to treat rare metabolic disorders and is known to be relatively safe.